Evidence map›Paper›PMID 31629403›Full record

Trial reportBMC neurology2019

Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis.

Wioletta Pawlukowska, Bartłomiej Baumert, Monika Gołąb-Janowska, Agnieszka Meller, Karolina Machowska-Sempruch, Agnieszka Wełnicka, Edyta Paczkowska, Iwona Rotter, Bogusław Machaliński, Przemysław Nowacki

Registry-linked trialOpen access · goldAbstract readClinical TrialComparative Study
In one paragraph

Trial report in BMC neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02193893 (Safety/Efficacy Study for the Biological Treatment of Amyotrophic Lateral Sclerosis With Autologous Stem/Progenitor Cells), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02193893 phase1unknown statusnot on this map

Safety/Efficacy Study for the Biological Treatment of Amyotrophic Lateral Sclerosis With Autologous Stem/Progenitor Cells

TypeinterventionalSponsorPomeranian Medical University SzczecinRan2010 to 2017Enrolled50ConditionsAmyotrophic Lateral SclerosisArmsBiological: Cell-based therapeutics, Symptomatic treatment of ALS
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Differentiating upper- and lower motor neuron diseases using automated acoustic analysis.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wioletta PawlukowskaDepartment of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian Medical University, Żołnierska 54, Szczecin, 71-210, Poland. wsna@o2.pl.ORCID http://orcid.org/0000-0002-4974-4292
Bartłomiej BaumertDepartment of General Pathology, Pomeranian Medical University, Unii Lubelskie 1, Szczecin, 71-252, Poland.
Monika Gołąb-JanowskaDepartment of Neurology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, 71-210, Poland.
Agnieszka MellerDepartment of Neurology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, 71-210, Poland.
Karolina Machowska-SempruchDepartment of Neurology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, 71-210, Poland.
Agnieszka WełnickaDepartment of Neurology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, 71-210, Poland.
Edyta PaczkowskaDepartment of General Pathology, Pomeranian Medical University, Unii Lubelskie 1, Szczecin, 71-252, Poland.
Iwona RotterDepartment of Medical Rehabilitation and Clinical Physiotherapy, Pomeranian Medical University, Żołnierska 54, Szczecin, 71-210, Poland.
Bogusław MachalińskiDepartment of General Pathology, Pomeranian Medical University, Unii Lubelskie 1, Szczecin, 71-252, Poland.
Przemysław NowackiDepartment of Neurology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, 71-210, Poland.
Pomeranian Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmyotrophic lateral sclerosis (ALS) is a fatal degenerative disease of a rapid course. In 25% of ALS sufferers, speech disorders occur as prodromal symptoms of the disease. Impaired communication affects physical health and has a negative impact on mental and emotional condition. In this study, we assessed which domains of speech are particularly affected in ALS. Subsequently, we estimated possible correlations between the ALS patients' subjective perception of their speech quality and an objective assessment of the speech organs carried out by an expert.

methodsThe study group consisted of 63 patients with sporadic ALS. The patients were examined for articulatory functions by means of Voice Handicap Index (VHI) and the Frenchay Dysarthria Assessment (FDA).

resultsOn the basis of the VHI scores, the entire cohort was divided into 2 groups: group I (40 subjects) with mild speech impairment, and group II (23 subjects) displaying moderate and profound speech deficits. In an early phase of ALS, changes were typically reported in the tongue, lips and soft palate. The FDA and VHI-based measurements revealed a high, positive correlation between the objective and subjective evaluation of articulation quality.

conclusionsDeterioration of the articulatory organs resulted in the reduction of social, physical and emotional functioning. The highly positive correlation between the VHI and FDA scales seems to indicate that the VHI questionnaire may be a reliable, self-contained tool for monitoring the course and progression of speech disorders in ALS.

trial registrationNCT02193893 .

Indexed as

AdultAgedAmyotrophic Lateral SclerosisDisease ProgressionFemaleHumansMaleMiddle AgedSpeechSpeech DisordersSpeech-Language PathologyAmyotrophic lateral sclerosisDysarthriaFrenchay Dysarthria AssessmentSpeech disordersVoice Handicap Index

Identifiers

PMID31629403
PMCPMC6800986
OpenAlexW2981019790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.